NASDAQ:NKTR

Nektar Therapeutics Stock Predictions

etoro logo Buy NKTR
*Your capital is at risk
$59.23
+0.670 (+1.14%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NKTR Prediction Chart

NKTR Predictions History

Latest community submissions for NKTR.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 28, 2025 $0.746 -3.71% $0.756 V 98.74% 2
Apr 28, 2025 $0.757 -2.32% $0.756 V 99.83% 6
Apr 28, 2025 $1.02 +38.16% $0.756 V 65.04% 0
Mar 12, 2025 $1.15 +40.38% $0.82 V 59.76% 1
Mar 12, 2025 $0.85 +3.93% $0.82 V 96.18% 1
Mar 12, 2025 $0.84 +2.45% $0.82 V 97.65% 1
Mar 12, 2025 $1.00 +21.95% $0.82 X 78.05% 1
Feb 11, 2025 $0.726 +3.69% $0.663 X 90.55% 0
Feb 11, 2025 $0.716 +2.31% $0.663 X 92.02% 0
Feb 11, 2025 Bullish $0.663 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NEKTAR THERAPEUTICS
Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE